CoChat

Hippocampal Interaction With Area 25, but not Area 32, Regulates Marmoset Approach–Avoidance Behavior

Open access

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

Abstract

Affective disorders are associated with increased sensitivity to negative feedback that influences approach–avoidance decision making. Although neuroimaging studies of these disorders reveal dysregulation in primate cingulate areas 25 and 32 and the anterior hippocampus (aHipp), the causal involvement of these structures and their interaction in the primate brain is unknown. We therefore investigated the effects of localized pharmacological manipulations of areas 25 and 32 and/or the aHipp of the marmoset monkey on performance of an anxiolytic-sensitive instrumental decision-making task in which an approach–avoidance conflict is created by pairing a response with reward and punishment. During control infusions animals avoided punishment, but this bias was reduced by increasing glutamate release within the aHipp or area 32, and inactivation or 5-HT1a antagonism within area 25. Conversely, increasing glutamate release in area 25 enhanced punishment avoidance but, in contrast to previous reports, area 32 and aHipp inactivations had no effect. Simultaneous inactivation or 5-HT1a antagonism within area 25, but not area 32, abolished the reduced punishment avoidance seen after increasing aHipp glutamate. Besides providing causal evidence that these primate areas differentially regulate negative feedback sensitivity, this study links the decision-making deficits in affective disorders to aberrant aHipp–area 25 circuit activity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cercor/bhz015

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Approach–avoidance paradigm and prefrontal cannulae placements. (A) Marmosets were presented with two identical visual stimuli presented to the left and right of a touch-sensitive computer screen. Touching either stimulus earned reward (5 s banana milkshake; blue drop) according to independent but identical reward schedules. Occasionally and in addition to the reward schedule, responding to one of the stimuli also earned a punishment (0.3 s 117 dB mildly aversive loud noise; bell) on a leaner independent variable interval schedule. (B) Under control conditions marmosets responded relatively equally to both stimuli, with a slight preference to their preferred side (P). Accordingly there is more responding to the preferred/to-be-punished side than the nonpreferred (NP)/nonpunished side under baseline conditions that is seen on both the infusion day and the day after (infusion day, t4 = 3.5, P = 0.024; next day, t4 = 3.03, P = 0.038). This bias was abolished when punishment was introduced on the preferred side as animals biased away from the punishment, towards the nonpreferred/nonpunished side. However, the day after the punishment/saline infusion, the preferential responding to the preferred side returned, and did not differ from equivalent baseline performance (F1,4 = 2.58, P = 0.18). Data represent mean number of responses after saline infusion into the aHipp and areas 25 and 32 ± standard error of the mean (SEM) (n = 5). *P < 0.05. (C) Sagittal marmoset MRI section illustrating the rostrocaudal targets of area 25, area 32, and aHipp infusions. (D) Schematics showing the intracerebral cannulae targeting area 25, area 32, and the aHipp (in the PFC areas, the double cannulae straddled the midline resulting in each unilateral area receiving a single cannula), the actual cannulae locations for each animal and representative histological sections with arrows marking the position of the cannulae. All cannulae are plotted onto a single coronal section for each target area and the AP range indicated. Cytoarchitectonic parcellation is according to Burman and Rosa (2009) and the circles represent the estimated maximal spread of the muscimol/baclofen or saline infusions (West et al. 2011).
Figure 1. Approach–avoidance paradigm and prefrontal cannulae placements. (A) Marmosets were presented with two identical visual stimuli presented to the left and right of a touch-sensitive computer screen. Touching either stimulus earned reward (5 s banana milkshake; blue drop) according to independent but identical reward schedules. Occasionally and in addition to the reward schedule, responding to one of the stimuli also earned a punishment (0.3 s 117 dB mildly aversive loud noise; bell) on a leaner independent variable interval schedule. (B) Under control conditions marmosets responded relatively equally to both stimuli, with a slight preference to their preferred side (P). Accordingly there is more responding to the preferred/to-be-punished side than the nonpreferred (NP)/nonpunished side under baseline conditions that is seen on both the infusion day and the day after (infusion day, t4 = 3.5, P = 0.024; next day, t4 = 3.03, P = 0.038). This bias was abolished when punishment was introduced on the preferred side as animals biased away from the punishment, towards the nonpreferred/nonpunished side. However, the day after the punishment/saline infusion, the preferential responding to the preferred side returned, and did not differ from equivalent baseline performance (F1,4 = 2.58, P = 0.18). Data represent mean number of responses after saline infusion into the aHipp and areas 25 and 32 ± standard error of the mean (SEM) (n = 5). *P < 0.05. (C) Sagittal marmoset MRI section illustrating the rostrocaudal targets of area 25, area 32, and aHipp infusions. (D) Schematics showing the intracerebral cannulae targeting area 25, area 32, and the aHipp (in the PFC areas, the double cannulae straddled the midline resulting in each unilateral area receiving a single cannula), the actual cannulae locations for each animal and representative histological sections with arrows marking the position of the cannulae. All cannulae are plotted onto a single coronal section for each target area and the AP range indicated. Cytoarchitectonic parcellation is according to Burman and Rosa (2009) and the circles represent the estimated maximal spread of the muscimol/baclofen or saline infusions (West et al. 2011).CC BY · PubMed Central
Figure 2. Overactivation of the aHipp abolishes punishment avoidance, but this response is prevented by simultaneous inactivation or 5-HT1a antagonism within area 25. Pharmacological manipulation of the aHipp and combined manipulations of the aHipp and either area 25 or area 32 produced differential effects on responding in the baseline reward (blue drop only) and approach–avoidance (blue drop and bell) conditions. Figures show the drug-induced changes in response bias (the ratio between the number of responses to the monkey’s nonpreferred side and the preferred side), the absolute response number and the relative responding to the preferred (P) and nonpreferred (NP) sides compared with saline controls. Data are represented as mean ± SEM. *P < 0.05. Response bias data is square root transformed for analysis. Inactivation of the aHipp with musbac did not affect responding in either the baseline reward or approach–avoidance condition, but overactivation with LY/CGP decreased punishment avoidance (Ai). No the alterations were seen in the overall number of responses (Fs < 1, NS; n = 5; Bi). Analysis of relative responding to the preferred and nonpreferred sides indicated that the alteration in behavior was selectively due to a reduction in responding to the punished side, and not an increase in responding to the nonpreferred side (Ci). Combining aHipp LY/CGP infusion with simultaneous inactivation of area 25, and to lesser extent antagonism of 5-HT1a receptors within area 25, abolished the reduction in punishment avoidance seen with independent aHipp LY/CGP infusion, area 25 inactivation and area 25 5-HT1a blockade (n = 4). The reduction seen after combined aHipp LY/CGP + musbac 25 was due to both a decrease in responding to the preferred/punished side, and an increase in responding to the nonpreferred side (Cii). Simultaneous inactivation of area 32 did not alter the effects of aHipp LY/CGP (n = 3; Aii). No alterations were seen in the overall number of responses (F > 1, NS; Bii). Musbac, muscimol/baclofen-mediated inactivation; LY/CGP, LY341495/CGP52432-mediated presynaptic glutamatergic disinhibition; WAY, WAY100135-mediated 5-HT1a antagonism. NP, nonpreferred side; P, preferred side.
Figure 2. Overactivation of the aHipp abolishes punishment avoidance, but this response is prevented by simultaneous inactivation or 5-HT1a antagonism within area 25. Pharmacological manipulation of the aHipp and combined manipulations of the aHipp and either area 25 or area 32 produced differential effects on responding in the baseline reward (blue drop only) and approach–avoidance (blue drop and bell) conditions. Figures show the drug-induced changes in response bias (the ratio between the number of responses to the monkey’s nonpreferred side and the preferred side), the absolute response number and the relative responding to the preferred (P) and nonpreferred (NP) sides compared with saline controls. Data are represented as mean ± SEM. *P < 0.05. Response bias data is square root transformed for analysis. Inactivation of the aHipp with musbac did not affect responding in either the baseline reward or approach–avoidance condition, but overactivation with LY/CGP decreased punishment avoidance (Ai). No the alterations were seen in the overall number of responses (Fs < 1, NS; n = 5; Bi). Analysis of relative responding to the preferred and nonpreferred sides indicated that the alteration in behavior was selectively due to a reduction in responding to the punished side, and not an increase in responding to the nonpreferred side (Ci). Combining aHipp LY/CGP infusion with simultaneous inactivation of area 25, and to lesser extent antagonism of 5-HT1a receptors within area 25, abolished the reduction in punishment avoidance seen with independent aHipp LY/CGP infusion, area 25 inactivation and area 25 5-HT1a blockade (n = 4). The reduction seen after combined aHipp LY/CGP + musbac 25 was due to both a decrease in responding to the preferred/punished side, and an increase in responding to the nonpreferred side (Cii). Simultaneous inactivation of area 32 did not alter the effects of aHipp LY/CGP (n = 3; Aii). No alterations were seen in the overall number of responses (F > 1, NS; Bii). Musbac, muscimol/baclofen-mediated inactivation; LY/CGP, LY341495/CGP52432-mediated presynaptic glutamatergic disinhibition; WAY, WAY100135-mediated 5-HT1a antagonism. NP, nonpreferred side; P, preferred side.CC BY · PubMed Central
Figure 3. Activity within area 25 and 32 has opposing roles in the regulation of punishment avoidance. Independent pharmacological manipulation of areas 25 and 32 produced differential effects on responding in the baseline reward (blue drop only) and approach–avoidance (blue drop and bell) conditions. Figures show the drug-induced changes in response bias, the absolute response number and the relative responding to the preferred and nonpreferred sides compared with saline controls. Data are represented as mean ± SEM. †Trend effect of manipulation. *P < 0.05. Response bias data is square root transformed for analysis. Inactivation or 5-HT1a antagonism within area 25 prevented the avoidance of punishment seen after saline infusion, while overactivation enhanced the avoidance of punishment (n = 4). Drug infusions did not affect performance in the baseline reward condition but did affect the approach–avoidance condition (Ai). Within the approach–avoidance condition, punishment avoidance was enhanced with LY/CGP and abolished with musbac. While LY/CGP caused this by both reducing responding to the preferred/punished side and increasing responding on the nonpreferred side, musbac selectively increased responding to the preferred side only (Ci). A similar trend towards abolition was seen with 5-HT1a antagonism. Manipulation of area 25 also altered the overall number of responses made (Bi). Inactivation of area 25 increased the number of responses in both conditions, while 5-HT1a antagonism had no effect. Area 25 LY/CGP increased the number of responses in the approach–avoidance condition only. Overactivation and inactivation of area 32 also had different effects on response bias in the 2 feedback conditions (n = 4; Aii). Infusions of musbac or LY/CGP did not affect performance in the baseline reward condition, and inactivation was without effect in the approach–avoidance condition. However, area 32 overactivation reduced the response bias to punishing feedback. No alterations were seen in the overall number of responses (Fs < 1, NS; Bii), and the response bias alteration was caused by a selective increase in responding to the preferred/punished side (Cii). Musbac, muscimol/baclofen-mediated inactivation; LY/CGP, LY341495/CGP52432-mediated presynaptic glutamatergic disinhibition; WAY, WAY100135-mediated 5-HT1a antagonism. NP, nonpreferred side; P, preferred side.
Figure 3. Activity within area 25 and 32 has opposing roles in the regulation of punishment avoidance. Independent pharmacological manipulation of areas 25 and 32 produced differential effects on responding in the baseline reward (blue drop only) and approach–avoidance (blue drop and bell) conditions. Figures show the drug-induced changes in response bias, the absolute response number and the relative responding to the preferred and nonpreferred sides compared with saline controls. Data are represented as mean ± SEM. †Trend effect of manipulation. *P < 0.05. Response bias data is square root transformed for analysis. Inactivation or 5-HT1a antagonism within area 25 prevented the avoidance of punishment seen after saline infusion, while overactivation enhanced the avoidance of punishment (n = 4). Drug infusions did not affect performance in the baseline reward condition but did affect the approach–avoidance condition (Ai). Within the approach–avoidance condition, punishment avoidance was enhanced with LY/CGP and abolished with musbac. While LY/CGP caused this by both reducing responding to the preferred/punished side and increasing responding on the nonpreferred side, musbac selectively increased responding to the preferred side only (Ci). A similar trend towards abolition was seen with 5-HT1a antagonism. Manipulation of area 25 also altered the overall number of responses made (Bi). Inactivation of area 25 increased the number of responses in both conditions, while 5-HT1a antagonism had no effect. Area 25 LY/CGP increased the number of responses in the approach–avoidance condition only. Overactivation and inactivation of area 32 also had different effects on response bias in the 2 feedback conditions (n = 4; Aii). Infusions of musbac or LY/CGP did not affect performance in the baseline reward condition, and inactivation was without effect in the approach–avoidance condition. However, area 32 overactivation reduced the response bias to punishing feedback. No alterations were seen in the overall number of responses (Fs < 1, NS; Bii), and the response bias alteration was caused by a selective increase in responding to the preferred/punished side (Cii). Musbac, muscimol/baclofen-mediated inactivation; LY/CGP, LY341495/CGP52432-mediated presynaptic glutamatergic disinhibition; WAY, WAY100135-mediated 5-HT1a antagonism. NP, nonpreferred side; P, preferred side.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 67 references

Cited by

See all 30

Metadata

Authors
Wallis, C. U., Cockcroft, G. J., Cardinal, R. N., Roberts, A. C., & Clarke, H. F.
Affiliations
University of Cambridge (GB)
Corresponding author
Clarke, Hannah F
Venue
Cerebral Cortex
Published
2019-02-23
Volume
29
Issue
11
Pages
4818-4830
ISSN
  • 1047-3211 (ISSN-L)
  • 1460-2199
OpenAlex
W2963846566
Cited by
30
References
67
Citations by year
2026: 1 · 2025: 4 · 2024: 3 · 2023: 2 · 2022: 4 · 2021: 5 · 2020: 6 · 2019: 5
FWCI
2.89
Type
journal article
Language
en
Open access
Locations
  • Cerebral Cortex (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Apollo (University of Cambridge) (submittedVersion)
  • Apollo
Funders
  • Career Development Award (RG62920)
  • Medical Research Council (MR/M023990/1)
  • Behavioral and Clinical Neuroscience Institute
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
hippocampus, approach-avoidance behavior, punishment avoidance, negative feedback sensitivity, glutamate release, neural inactivation, marmoset monkey, mood disorders, decision-making, anterior hippocampus
MeSH terms
Animals, Avoidance Learning, Callithrix, Choice Behavior, Conflict, Psychological, Decision Making, Female, Hippocampus, Male, Punishment, Reward, Prefrontal Cortex, Glutamic Acid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hippocampal Interaction With Area 25, but not Area 32, Regulates Marmoset Approach–Avoidance Behavior. https://app.cochat.ai/papers/10.1093/cercor/bhz015
The paper
Wallis, C. U., Cockcroft, G. J., Cardinal, R. N., Roberts, A. C., & Clarke, H. F. (2019). Hippocampal Interaction With Area 25, but not Area 32, Regulates Marmoset Approach–Avoidance Behavior. Cerebral Cortex. https://doi.org/10.1093/cercor/bhz015

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.